Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 5.22% | 1.65% | 1.65% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 5.22% | 1.65% | 1.65% |
The Gabelli ABC Fund delivered a 1.65% return in Q1 2026, benefiting from strong M&A activity that reached $1.2 trillion in announced transactions, up 27% from the prior year. The fund's arbitrage strategy capitalized on event-driven opportunities including major biotechnology deals such as Gilead's acquisition of Arcellx for $115 per share and Danaher's acquisition of Masimo for $180 per share. Energy holdings provided additional returns as the Iran conflict drove oil prices higher, with positions in APA Corp and ONEOK performing well. Technology, Energy, and Financials led deal activity, accounting for over half of transactions, while private equity deals increased 41% year-over-year. Top contributors included closed deals like TEGNA and ongoing positions in Millicom International Cellular. The fund maintains exposure to pending deals including AES Corp and Tri Pointe Homes. Management expects continued M&A momentum supported by economic stability and tax benefits, though monitoring geopolitical risks and private credit concerns.
The Gabelli ABC Fund focuses on arbitrage strategies and event-driven situations including announced mergers, spin-offs, and reorganizations to achieve attractive total returns without excessive capital loss risk.
Management expects strong M&A activity to continue well into 2026 supported by relatively steady economy and positive impacts from tax legislation. However, dealmakers will monitor Iranian conflict and higher energy prices along with concerns about private credit and AI disruption.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| May 26 2026 | 2026 Q1 | ACLX, MASI | arbitrage, Biotechnology, Deal Activity, energy, Iran Conflict, M&A | - | Gabelli ABC Fund gained 1.65% in Q1 2026 from strong M&A activity totaling $1.2 trillion in deals, up 27% year-over-year. Arbitrage strategy benefited from biotech acquisitions and energy sector strength during Iran conflict. Fund positioned in pending deals including AES Corp and Tri Pointe Homes with continued M&A momentum expected. |
| Feb 18 2026 | 2025 Q4 | CFLT, EXAS, FOX, FRGE, GTLS, HOLX, KKR, KMB, KVUE, LEN, NEM, NFG, NFLX, PAAS, PSKY, TGNA, TXNM, WBD | arbitrage, healthcare, industrials, M&A, private equity, technology |
GTCH EXAS HOLX ALE |
The Gabelli ABC Fund gained 0.45% in Q4 amid record M&A activity totaling $4.6 trillion for 2025. The Fund capitalized on event-driven opportunities including major biotech acquisitions and megadeals like Netflix's Warner Bros. Discovery bid. Strong deal flow across technology, industrials, and financials sectors positions the strategy well for continued M&A momentum in 2026. |
| Nov 16 2025 | 2025 Q3 | AAPL, AMETEK, AMZN, AXP, BK, BRK.B, CAT, CNH, DE, GOOGL, ITT, META, MSFT, MSGS, NEM, NFLX, NVDA, RSG, SONY, TSLA, WBD | AI, energy, financials, gold, M&A, rates, technology, Trade |
ECG US OR US |
Markets climbed 8.1% in Q3 driven by AI enthusiasm and broadening rally despite trade tensions. Fed cut rates 25bps with more expected while gold hit $4,000 on fiscal concerns. M&A activity surged 33% as regulatory environment improved. Despite 30x earnings valuations, opportunities exist in overlooked small-mid caps using Private Market Value approach. |
| Jun 30 2025 | 2025 Q2 | AAPL, AMZN, BATRA, CHWY, CZR, FOX, GOOGL, IDXX, IVG.MI, META, MSFT, MSGS, NFLX, NVDA, SBGI, TDS, TGNA, TSLA, WBD, ZTS | AI, defense, Mergers & Acquisitions, private market value, Sports, tariffs, Utilities, Value Investing | SWTX | GAMCO navigates Q2 2025's policy-driven volatility through disciplined Private Market Value investing. Trade uncertainty, fiscal stimulus, and institutional trust erosion create complex backdrop. Key opportunities emerge in AI infrastructure, defense spending, utilities transformation, and sports entertainment. Firm remains cautious on market multiples while finding value in domestic small caps and international markets. Volatility benefits patient capital deployment. |
| Mar 31 2025 | 2025 Q1 | AB, AZEK, BECN, FOXA, FYBR, GABCX, ITCI, IVAC, JNJ, JNPR, KKR, LEN, LGTY, TGNA, TXNM, VZ, WBA | Acquisitions, arbitrage, Event-Driven, Mergers, Regulatory | - | The Gabelli ABC Fund employs arbitrage strategies focused on merger and acquisition opportunities. Q1 2025 saw $885 billion in global M&A activity despite regulatory headwinds under the new Trump administration. The fund benefited from deals like Johnson & Johnson's $14.6 billion acquisition of Intra-Cellular Therapies, while positioning for continued M&A acceleration driven by competitive pressures and available private equity capital. |
| Dec 31 2024 | 2024 Q4 | ALE, AXNX, CNHI, CTLT, FOX, JNPR, KKR, LEN, NAPA, NFG, SCWX, SJI, SRDX, TGNA, TXNM | arbitrage, Capital markets, Event Driven, M&A, Mergers | - | The Gabelli ABC Fund returned 1.47% in Q4 2024, benefiting from merger arbitrage strategies as global M&A activity reached $3.2 trillion. The Trump administration's expected lighter antitrust enforcement should spur deal activity after years of regulatory headwinds. The fund maintains positions in pending mergers while capitalizing on completed transactions across technology, energy, and financial sectors. |
| Sep 30 2024 | 2024 Q3 | BSX, CHUY, FOXA, FTR, INST, JNPR, K, KKR, LBTYK, LEN, MARS, PRY, SRDX, TXNM, VZ, VZIO, WIRE | arbitrage, Deal Activity, M&A, private equity, technology | - | The Gabelli ABC Fund capitalizes on robust M&A activity through arbitrage strategies in announced deals. Global M&A reached $2.3 trillion through nine months, up 16% year-over-year, led by technology sector consolidation. Fed rate cuts support deal financing while potential regulatory changes may improve transaction approval processes, creating favorable conditions for the Fund's event-driven investment approach. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
Biopharma M&AStrong M&A activity in biotechnology sector with multiple deals including Gilead's acquisition of Arcellx for $115 per share, Danaher's acquisition of Masimo for $180 per share, and Merck's acquisition of Terns Pharmaceuticals for $53 per share. These transactions highlight continued consolidation in the biotech space. |
Mergers Biotechnology Acquisitions Healthcare |
EnergyEnergy sector benefited from Iran conflict driving oil prices higher. Devon Energy's $21 billion acquisition of Coterra Energy was a major deal. Energy holdings like APA Corp and ONEOK performed well during the quarter as geopolitical tensions supported commodity prices. |
Oil Natural Gas Geopolitics Iran | |
Capital MarketsM&A volume reached $1.2 trillion in Q1, up 27% from prior year, marking the third consecutive quarter exceeding $1 trillion. Technology, Energy, and Financials were top sectors for deal activity. Private equity transactions increased 41% year-over-year. |
M&A Deal Volume Private Equity Transactions | |
| 2025 Q4 |
Live SportsMario Gabelli emphasizes live entertainment and sports as major investment themes, citing massive viewership numbers and recommending Atlanta Braves Holdings, Madison Square Garden Sports, and Manchester United as core positions with significant upside potential. |
Sports Entertainment Media Valuation |
AIAI is described as transformative and accelerating across the economy, but Gabelli warns of potential disappointment for investors and compares current dynamics to late 1990s tech speculation with risks of market correction. |
Technology Semiconductors Disruption Valuation | |
Natural GasNational Fuel Gas is recommended based on substantial Appalachian Basin reserves strategically located near population centers, with the value of gas reserves being unappreciated by the market. |
Energy Utilities Infrastructure Reserves | |
GoldGold expert Caesar Bryan's fund returned 167% in 2025, with gold serving as a store of value amid monetary uncertainty and geopolitical tensions, particularly for governments seeking alternatives to dollar holdings. |
Precious Metals Store of Value Monetary Policy | |
| 2025 Q3 |
AIArtificial Intelligence continues to be the primary driver of market returns, with most of the Magnificent Seven at or near all time highs. The scale of investment in AI infrastructure continues to surpass expectations, with the five largest cloud computing platforms communicating capex plans for 2025 aggregating to approximately $380 billion. |
Infrastructure Investment Technology Cloud |
Trade PolicyTrade continues to be in flux, with the U.S. signing deals with many partners including the UK and European Union, though uncertainty remains for significant countries including China and India. The average U.S. tariff has decreased from 23% in April to 17.5% currently. |
Tariffs China Uncertainty Negotiations | |
GoldGold and bitcoin extended their rallies with gold reaching nearly $4,000 per ounce and bitcoin at $120,000, driven by fiscal concerns and search for real-asset hedges amid $37 trillion in national debt and $2 trillion annual budget deficit. |
Inflation Hedge Fiscal Debt | |
RatesThe Federal Reserve cut rates for the first time this year in September, lowering the Fed Funds rate 25 bps to 4%-4.25%, with expectations for further cuts. 10 Year U.S. Treasury yields declined during the quarter and are currently around 4.1%. |
Fed Monetary Treasury Easing | |
BuybacksMany financial institutions continued their multi-year share repurchase plans, with companies like Bank of New York Mellon repurchasing 1.4% of shares and Standard Chartered reducing share count by 2.3% in the quarter. |
Repurchase Capital Returns Allocation | |
| 2025 Q2 |
AIMajor AI infrastructure platforms remained committed to aggressive investment with the five largest global data center operators communicating 2025 capex plans aggregating to ~$330bn. Adoption of generative AI services has inflected sharply with ChatGPT's Weekly Active Users doubling since the start of the year and Alphabet's Gemini reporting 50x year-over-year growth in tokens generated. |
Data Centers Cloud Semiconductors Enterprise Software Automation |
Trade PolicyThe Three T's dominated investor attention with Trade uncertainty hampering spending decisions by businesses and consumers. Liberation Day tariffs triggered market volatility but a 90-day pause provided relief. The effective weighted average tariff rate is anticipated at nearly 18% incorporating recent bilateral trade deals. |
Tariffs Trade War Globalization Supply Chain Inflation | |
Defense SpendingEuropean defense budgets are rising sharply with 31 of 32 NATO member nations committing to boost defense spending to 5% of GDP by 2035, roughly double current levels. Companies like Saab and defense contractors are benefiting from increased spending and NATO expansion. |
NATO Military Aerospace Defense Electronics Government IT | |
Live SportsGrowing enthusiasm about the world of sports with more people buying tickets to sporting events and sports broadcasting vital to companies. Major sports leagues now allow up to 30% private-equity ownership of individual teams, increasing their value. The growth of the Hispanic market is favorable for baseball and sports gambling is growing. |
Entertainment Media Sports Betting Event Ticketing Gaming | |
Energy TransitionUtilities are responding with record capital investment in generation and grid upgrades as electricity demand grows at its fastest pace since the mid-20th century, driven by AI-powered data centers, reshoring of manufacturing, and electrification of transport. |
Renewable Developers Grid Upgrade Nuclear Energy Storage Smart Grid | |
Pet CarePet ownership has reached new highs with 94 million U.S. households now owning at least one pet, up from 82 million just two years ago. Gen Z shows a 43.5% increase in pet ownership with a notable tendency to own multiple pets, driving demand for premium products and services. |
Veterinary Pet Products Animal Health E-commerce Consumer Discretionary | |
| 2025 Q1 |
Biopharma M&AThe fund invested in Intra-Cellular Therapies, which agreed to be acquired by Johnson & Johnson for $132 cash per share, valuing the transaction at approximately $14.6 billion. This represents a significant pharmaceutical merger and acquisition opportunity. |
Johnson & Johnson Intra-Cellular Therapies pharmaceutical acquisition merger |
Capital MarketsThe fund focuses on arbitrage strategies and event-driven situations including announced mergers, spin-offs, split-ups, liquidations, and reorganizations. Regulatory scrutiny remained at the forefront with two transactions sued by DOJ and FTC within weeks of Trump's inauguration. |
arbitrage mergers acquisitions regulatory antitrust | |
| 2024 Q4 |
Capital MarketsM&A activity totaled $3.2 trillion globally in 2024, a 10% increase from 2023. Technology, energy and power, and financials were the most active sectors. Private equity-backed transactions contributed 22% to total deal volumes. The new Trump administration is expected to spur a resurgence of deal activity with less strict antitrust enforcement. |
M&A Arbitrage Deal Activity Antitrust Private Equity |
| 2024 Q3 |
Biopharma M&AThe technology sector remained the most active with $375 billion worth of new deals announced in the first three quarters of 2024, representing a 29% year-over-year increase. Notable transactions included Mars Company's agreement to acquire Kellanova for $28.8 billion and Verizon's arrangement to acquire Frontier Communications for $9.6 billion. |
M&A Technology Consolidation Deal Activity Private Equity |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | GTCH | Chart Industries, Inc. | Industrials | Industrial Machinery | Bull | New York Stock Exchange | acquisition, arbitrage, energy, Industrials, LNG | Login |
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | EXAS | Exact Sciences Corporation | Health Care | Health Care Services | Bull | NASDAQ | diagnostics, growth, Oncology, Reimbursement, Screening | Login |
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | HOLX | Hologic, Inc. | Health Care | Health Care Equipment | Bull | NASDAQ | arbitrage, cashflow, diagnostics, Imaging, private equity | Login |
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | ALE | ALLETE, Inc. | Utilities | Electric Utilities | Bull | New York Stock Exchange | arbitrage, cash, infrastructure, Regulation, utilities | Login |
| Nov 16, 2025 | Fund Letters | Mario J. Gabelli | ECG US | Everus Construction Group, Inc. | Industrials | Construction & Engineering | Bull | NYSE | backlog, construction, data centers, Electrification, infrastructure | Login |
| Nov 16, 2025 | Fund Letters | Mario J. Gabelli | OR US | OR Royalties Inc. | Materials | Precious Metals Royalty & Streaming | Bull | NYSE | Gold, low leverage, Optionality, royalties, Streaming | Login |
| Jun 30, 2025 | Fund Letters | Mario J. Gabelli | SWTX | SpringWorks Therapeutics, Inc. | Health Care | Biotechnology | Bull | NASDAQ | acquisition, Approval, arbitrage, Biotech, cashflow, Oncology, pipeline, Spread | Login |
| TICKER | COMMENTARY |
|---|---|
| ACLX | Arcellx Inc. is a biotechnology company focused on developing immunotherapy for patients with multiple myeloma. Gilead Sciences agreed to acquire ACLX for $115 per share in cash on February 23. U.S. antitrust approval has already been received. The deal remains subject to foreign approvals. The tender offer will expire on April 24, and the deal is expected to close shortly after. |
| MASI | Masimo Corp. is a specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Danaher agreed to acquire MASI for $180.00 per share in cash. The shareholder meeting is scheduled for May 1. The transaction also remains subject to U.S. antitrust approval and various foreign regulatory approvals. It is expected to be completed in the second half of 2026. |
| TPH | Tri Pointe Homes Inc. is a homebuilder with a presence across the Western, Southwestern, and Southeastern United States. Sumitomo Forestry agreed to acquire TPH for $47.00 per share in cash. The shareholder meeting is scheduled for April 16. The transaction also remains subject to U.S. antitrust approval. It is expected to be completed in the second quarter of 2026. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||